GGrantIndex
Sort

50,496 grants matching lung cancer

Profiling cancer neoantigen repertoires and validating immunotherapy targets

$1,047,882
Martin W McIntosh · Fred Hutchinson Cancer Research Center · U01 · FY2014 · CA

DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs

$1,047,789
Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Development of Combination Therapies to Delay/Prevent Acquired Drug Resistance

$1,047,525
Pasi A Janne · Dana-Farber Cancer Inst · R35 · FY2021 · CA

Development of Combination Therapies to Delay/Prevent Acquired Drug Resistance

$1,047,525
Pasi A Janne · Dana-Farber Cancer Inst · R35 · FY2020 · CA

Development of Combination Therapies to Delay/Prevent Acquired Drug Resistance

$1,047,525
Pasi A Janne · Dana-Farber Cancer Inst · R35 · FY2018 · CA

PFI: BIC: WearNet: Wearable Nanoplasmonic Biosensing Networks for Smart Health Monitoring & Diagnosis

$1,047,141
Josep M Jornet · Suny At Buffalo · · FY2017 · TIP

Pharmacogenetic Studies

$1,046,660
Neil E. Caporaso · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA

Post-transcriptional control of Proliferation, Stress Response & Carcinogenesis

$1,046,405
Myriam Gorospe · National Institute On Aging · ZIA · FY2016 · AG

Determining the Fate of Transmembrane Proteins

$1,045,410
Allan M Weissman · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

IGF::OT::IGF HHSN261201600007I/HHSN26100001, POP 03/01/2016 - 02/28/2017, PRIMARY PRODUCT/SERVICE CODE TO: B537, DESCRIPTION: CENTRAL DATA COLLECTION CENTER (CDCC), WESTAT

$1,045,358
Sunitha Mathew · Westat, Inc. · N02 · FY2017 · CA

Georgia NCI Community Oncology Research Program (NCORP)

$1,045,219
Guilherme Cantuaria · Northside Hospital Atlanta · UG1 · FY2016 · CA

Comparative Biomedical Scientist Training Program

$1,045,163
Robert Simpson · Division Of Basic Sciences - Nci · ZIG · FY2009 · CA

Clinical Protocol and Data Management (Core 012)

$1,045,017
Dan Toby Vogl · University Of Pennsylvania · P30 · FY2016 · CA

Transgenic Models for Prostate and Breast Cancer

$1,044,851
Jeffrey E Green · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

Mechanical Regulation of Cell Adhesion

$1,044,672
Clare Michal Waterman · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL

Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery

$1,044,600
Matthew L Meyerson · Dana-Farber Cancer Inst · R35 · FY2025 · CA

Computer Support for Lung Cancer Screening in the PLCO Cancer Screening Trial

$1,044,482
William Lake · Information Management Services, Inc. · N02 · FY2009 · CA

MMC, VICC & TSU: Partners in Eliminating Cancer Disparities ( 2 of 3)

$1,044,393
Harold L Moses · Vanderbilt University · U54 · FY2012 · CA

Suppressors of kRAS Activity Discovered Using a Fruit Fly-based In-vivo Screen

$1,043,722
William A. Garland · Tosk, Inc. · R44 · FY2017 · CA

Coordinating center for the NCI small cell lung cancer research consortium

$1,043,471
Charles M Rudin · Sloan-Kettering Inst Can Research · U24 · FY2019 · CA

DNA evaluation of fragments for early interception (DELFI) of Lung cancer

$1,043,393
Victor E Velculescu · Johns Hopkins University · U01 · FY2025 · CA

Determining the Fate of Transmembrane Proteins

$1,043,252
Allan M Weissman · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Multidisciplinary Training Program in Lung Disease

$1,043,093
Dean Sheppard · University Of California, San Francisco · T32 · FY2017 · HL

Mass Spectrometry Quantitation

$1,042,847
Leesa Deterding · National Institute Of Environmental Health Sciences · ZIC · FY2018 · ES

Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)

$1,042,800
Sten H Vermund · Vanderbilt University · R25 · FY2012 · TW